Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 2013

View Archived Issues

Derma Sciences begins enrollment in phase III DSC-127 trial

CX3CR1 gene polymorphisms investigated in multiple sclerosis

DNA-binding protein SATB1 associated with aggressive prostate cancer

Merck & Co. prepares new BTK inhibitors

Abbott Laboratories presents novel CCR2 receptor antagonists

Spanish researchers disclose new DP2 receptor antagonists

MorphoSys divulges new bispecific monoclonal antibodies

Nihon University discloses novel apoptosis inducers

Novel DPP IV inhibitors synthesized at Boehringer Ingelheim

AstraZeneca patents new MCH1 receptor antagonists

Scientists at Janssen Pharmaceuticals present new gamma-secretase modulators

Avanir Pharmaceuticals reports interim data for AVP-786

Intellect Neurosciences begins preclinical proof-of-concept studies for TauC3

Bevacizumab improves survival in patients with cervical cancer

TGFR-1 inhibitor prevents metastasis in animal models of breast cancer

Gilead Sciences completes acquisition

Shire begins phase III study in epidermolysis bullosa

FDA issues draft guidance on developing drugs for early Alzheimer's disease

Data from phase II Reolysin trial in lung cancer reported

Glucokinase plus insulin genetic therapy cures diabetes in dogs

Phospho-p90RSK6 as a predictive marker in ER-positive breast cancer

EMA committee begins safety review of Diane-35 and generics

Bayer HealthCare to coordinate newly founded pan-European consortium

FDA approves second drug for multiple myeloma

RNL Bio seeks Korean clearance for phase II/III trials of stem cell product

Novo Nordisk receives complete response letter for Tresiba and Ryzodeg

Bayer HealthCare files applications for riociguat in U.S. and Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026